3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
35
Lymphoma, Large B-Cell, Diffuse
22
Sarcoma
19
Lymphoma
19
Carcinoma, Hepatocellular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Non-Hodgkin
9
Hodgkin Disease
9
Multiple Myeloma
8
Leukemia
8
Neuroblastoma
6
Liver Neoplasms
6
Lymphoma, Follicular
5
Immunoblastic Lymphadenopathy
5
Ovarian Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Neoplasms, Plasma Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Liposarcoma
3
Leiomyosarcoma
3
Chondrosarcoma
3
Burkitt Lymphoma
3
Wilms Tumor
2
Rhabdomyosarcoma
2
Interventions
Drug Therapy
2
onapristone
1
olaparib
1
niraparib
1
golotimod
1
anlotinib
1
abiraterone
1
Sorafenib
1
Sodium Chloride
1
Pluvicto
1
Photochemotherapy
1
Nivolumab
1
Ipilimumab
1
Doxorubicin
1
Docetaxel
1
Chemoradiotherapy
1
Capecitabine
1
Botulinum Toxins, Type A
1
Biopsy, Needle
1
Bevacizumab
1
Aspirin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms by Site
×
Doxorubicin
×
Clear all
NCT01204801
2015-09-24
Medifocus301
Medifocus, Inc.
Phase 3
Unknown
238 enrolled